Fort Washington, PA USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

NCCN Publishes New Patient Education Resources for Kidney Cancer

NCCN has published the NCCN Guidelines for Patients® and NCCN Quick Guide™ for Kidney Cancer, the newest addition to the library of NCCN Guidelines for Patients.
25-Aug-2015 2:10 PM EDT Add to Favorites

NCCN Seeking Poster Presentations from Nation’s Top Oncology Researchers

NCCN is now accepting original abstracts from investigators for consideration for the NCCN 21st Annual Conference General Poster Session; the deadline for submissions is Friday, November 6, 2015.
3-Aug-2015 10:15 AM EDT Add to Favorites

NCCN Receives $2 Million in Research Funding from Boehringer Ingelheim to Study Targeted Combination Approaches with Afatinib in Lung Cancer

The NCCN Oncology Research Program (ORP) received a $2-million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to facilitate studies of afatinib in non-small cell lung cancer.
11-Jun-2015 9:35 AM EDT Add to Favorites

NCCN Collaborates with Pfizer to Improve Provider Performance and Quality in Treatment of Metastatic Breast Cancer

NCCN and Pfizer will elicit grant proposals for quality improvement and education in metastatic breast cancer.
2-Jun-2015 1:15 PM EDT Add to Favorites

Oncology Experts to Deliberate Tissue Allocation Issues at Upcoming NCCN Policy Summit

The National Comprehensive Cancer Network® (NCCN®) will host Emerging Issues in Tissue Allocation, on June 8, 2015, at the National Press Club in Washington, DC.
1-Jun-2015 2:35 PM EDT Add to Favorites

Flatiron Health to Incorporate NCCN Chemotherapy Order Templates into OncoEMR®

The integration of the NCCN Chemotherapy Order Templates (NCCN Templates®) into the Flatiron Health OncoEMR® electronic health record will allow for access to evidence-based treatment protocols based on the NCCN Clinical Practice Guidelines in...
18-May-2015 9:30 AM EDT Add to Favorites

NCCN Receives $2-Million Funding Commitment from ImmunoGen, Inc. to Study Mirvetuximab Soravtansine for Folate Receptor Alpha-Positive Cancers

The NCCN Oncology Research Program (ORP) has received a $2-million grant from ImmunoGen, Inc. to facilitate preclinical and clinical research with mirvetuximab soravtansine for Folate Receptor Alpha-positive cancers at NCCN Member Institutions and...
15-May-2015 11:00 AM EDT Add to Favorites

NCCN Foundation® Awards Grants to Six Young Investigators

The NCCN Foundation® has awarded its fifth series of Young Investigator Awards to six oncology researchers from NCCN Member Institutions; the awards provide grants of $150,000 over a two-year period for research initiatives focused on assessing and...
6-Apr-2015 12:15 PM EDT Add to Favorites

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos